腱炎治療の市場規模、シェア、動向分析レポート：治療法（治療、手術）、症状（テニス肘、ゴルファー肘）、地域（アジア太平洋、北米）、セグメント別予測、2022年～2030年

腱炎治療市場の成長と動向

グランドビューリサーチ社の最新レポートによると、世界の腱炎治療市場規模は2030年までに2818億米ドルに達し、予測期間中に3.7%のCAGRを記録すると予測されています。身体活動やスポーツ活動への参加者の増加は、スポーツ関連傷害の有病率の上昇に直接影響します。さらに、労働災害の発生率が上昇していることも、予測期間中の業界の発展と成長に貢献すると予想されます。世界の老齢人口の増加により、骨障害、糖尿病、関節炎、骨関節炎、骨粗鬆症、腱炎などの影響を受けやすくなっています。腱炎を管理するための高度な治療法や技術を常に革新している市場参入企業も、市場の成長に寄与しています。

投資の拡大、業界コラボレーション、政府による支援の増加も、市場成長を加速させる重要な要因となっています。過去数年にわたり、スポーツ選手の怪我を防ぐための健康管理において、予防的な治療法への移行が進んでいます。Standard Children's Healthによると、2018年には、米国でスポーツ活動に参加している3000万人の青少年のうち、約350万人がスポーツ関連の怪我を負っています。調査によると、毎年、米国では約775,000人の青少年がスポーツ関連傷害の治療や処置を受けています。大手企業は、製品のイノベーションと流通サイクルの強化を通じて、先進国と新興国の両方で事業の足跡を拡大しています。

COVID-19が大流行し、各国で施錠や旅行制限が行われた際、腱炎の治療件数が減少したため、業界の成長にマイナスの影響を及ぼしました。スポーツイベントの延期や中止により、スポーツ関連傷害の発生率が低下し、市場の業績が低下しました。2021年には、治療分野が最大のシェアを占め、予測期間中に大きく成長すると予想されます。これは、非侵襲的な治療手順への高い嗜好性に起因しています。治療管理の第一線は理学療法であり、これはかなりの成長を示すと予想されます。

2021年には、アキレス腱炎セグメントが業界を支配しました。この成長は、スポーツ選手のスポーツ関連傷害の発生率が高まっていることに起因しています。研究により、アキレス腱炎の発生率は、10万人あたり5～10人の間です。北米は、有名メーカーや販売業者の存在、スポーツ関連および外傷の発生率の増加、さまざまな治療法および外科的処置の利用可能性に関する認知度の上昇により、2021年に最大のシェアを占めました。

腱炎治療市場のレポートハイライト

スポーツイベントへの参加者の増加により、負傷者数が増加し、治療や手術が必要となるため、予測期間中に大きな成長が見込まれています。

革新的で高度なソリューションの出現が、予測期間中の業界成長の要因となっている

2021年には、腱炎に対する外科的処置よりも非侵襲的な治療への嗜好の高まりにより、療法治療セグメントが最大の収益シェアを占めました。

2021年、スポーツ傷害の増加により、アキレス腱炎が最大の売上高を占めました。

北米は2021年において最大の地域であり、同地域で実施された手術の数が多いため

目次

第1章 調査手法と範囲

• 市場セグメンテーションと範囲
• 調査手法
• 情報調達
  • 購入したデータベース：
  • GVRの内部データベース
  • 二次情報
  • 1次調査：
  • 1次調査内容
• 二次情報一覧
• 一次情報のリスト
• 情報またはデータ分析
  • データ分析モデル
• 市場の策定と検証
  • アプローチ1：コモディティフローアプローチ
  • 世界市場：CAGR計算
• 略語
• 報告の目的

第2章 エグゼクティブサマリー

• 市場の見通し
• セグメントの見通し
• 競争力の見通し
• 腱炎市場の概要、2021年

第3章 腱炎治療市場の変数、動向、範囲

• 市場系列の見通し
  • 親市場分析
  • 補助的な市場分析
• 浸透と成長の見通しのマッピング
• 価格分析
• 製品パイプライン分析
• 業界分析
  • 消費者行動分析
  • 市場インフルエンサー分析
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • MEA
  • 製品別の主要なエンドユーザーのリスト
• 規制の枠組み
  • 償還の枠組み
  • 規格とコンプライアンス
    • CPTコーディングの影響
    • HCPCSコーディングの意味
  • 安全性
• 腱炎治療市場力学
  • 市場促進要因分析
    • スポーツ外傷の増加
    • 新製品開発に係る技術進歩
    • 腱炎の治療オプションに対する意識の高まり
  • 市場抑制要因分析
    • 新興国では保険適用範囲が限られている
• 腱炎治療市場分析ツール
  • 業界分析- ポーター
    • サプライヤーの力- 適度に高い
    • 買い手の交渉力- 中程度
    • 代替品の脅威-中程度
    • 新規参入業者の脅威-低
    • 競争力- 高い
  • PESTEL分析
    • 政治情勢
    • 経済情勢
    • 社会情勢
    • テクノロジー情勢
    • 環境情勢
    • 法的情勢
• 主要取引と戦略的提携分析

第4章 腱炎治療市場：競合分析

• 市場参加の分類
  • 地域ネットワークマップ
  • イノベーター
  • 主要企業の市場シェア分析、2021年
  • 地域別の企業市場シェア、2021年
• 公開会社
  • 企業の市況分析
  • ヒートマップ分析
• 非公開会社
  • 新興企業一覧
  • ヒートマップ分析
• ベンダー情勢
  • 主要なディストリビューターとチャネルパートナーのリスト
  • 主要顧客

第5章 腱炎治療市場：治療推定・動向分析

• 治療市場シェア分析、2021年および2030年
• 治療ダッシュボード
  • 治療
    • ホット＆コールドセラピー
    • 理学療法
    • 衝撃波療法
  • 手術

第6章 腱炎治療市場：状態推定・動向分析

• 状態の市場シェア分析、2021年および2030年
• 状態ダッシュボード
  • テニス肘
  • ゴルファーの肘
  • 投手の肘
  • ジャンパーズニー
  • スイマーの肩
  • アキレス腱炎

第9章 腱炎治療市場：治療別、条件別の地域推定・動向分析

• 地域ダッシュボード
• 地域市場のスナップショット
• 世界の腱炎治療市場：地域動向変動分析
• 国別の市場シェア分析、2021年
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • MEA
• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ロシア
• アジア太平洋地域
  • 日本
  • 中国
  • インド
  • 韓国
  • シンガポール
  • オーストラリア
• ラテンアメリカ
  • メキシコ
  • ブラジル
  • アルゼンチン
• MEA
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第10章 企業プロファイル

• Merck &Co. Inc
  • 会社概要
  • 財務実績
  • 製品のベンチマーク
  • 戦略的イニシアチブ
• AstraZeneca
  • 会社概要
  • 財務実績
  • 製品のベンチマーク
  • 戦略的イニシアチブ
• Boehringer Ingelheim Pharmaceuticals, Inc
  • 会社概要
  • 財務実績
  • 製品のベンチマーク
  • 戦略的イニシアチブ
• Abbott
  • 会社概要
  • 財務実績
  • 製品のベンチマーク
  • 戦略的イニシアチブ
• Pfizer
  • 会社概要
  • 財務実績
  • 製品のベンチマーク
  • 戦略的イニシアチブ
• Bayer AG
  • 会社概要
  • 財務実績
  • 製品のベンチマーク
  • 戦略的イニシアチブ
• GlaxoSmithKline, PLC
  • 会社概要
  • 財務実績
  • 製品のベンチマーク
  • 戦略的イニシアチブ
• Almatica Pharma, Inc
  • 会社概要
  • 財務実績
  • 製品のベンチマーク
  • 戦略的イニシアチブ
• Teva Pharmaceuticals Industries
  • 会社概要
  • 財務実績
  • 製品のベンチマーク
  • 戦略的イニシアチブ

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviation
• Table 3 Product pipeline/clinical stage
• Table 4 CPT coding
• Table 5 HCPCS coding
• Table 6 ICD-10-CM coding
• Table 7 List of emerging companies in tendonitis treatment market
• Table 8 North America Tendonitis Treatment market, by country, 2016 - 2030 (USD Million)
• Table 9 North America Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
• Table 10 North America Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)
• Table 11 U.S. Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
• Table 12 U.S. Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)
• Table 13 Canada Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
• Table 14 Canada Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)
• Table 15 Europe Tendonitis Treatment market, by country, 2016 - 2030 (USD Million)
• Table 16 Europe Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
• Table 17 Europe Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)
• Table 18 U.K. Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
• Table 19 U.K. Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)
• Table 20 Germany Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
• Table 21 Germany Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)
• Table 22 France Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
• Table 23 France Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)
• Table 24 Spain Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
• Table 25 Spain Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)
• Table 26 Italy Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
• Table 27 Italy Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)
• Table 28 Russia Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
• Table 29 Russia Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)
• Table 30 Asia Pacific Tendonitis Treatment market, by country, 2016 - 2030 (USD Million)
• Table 31 Asia Pacific Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
• Table 32 Asia Pacific Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)
• Table 33 China Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
• Table 34 China Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)
• Table 35 Japan Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
• Table 36 Japan Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)
• Table 37 India Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
• Table 38 India Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)
• Table 39 Singapore Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
• Table 40 Singapore Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)
• Table 41 Australia Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
• Table 42 Australia Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)
• Table 43 South Korea Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
• Table 44 South Korea Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)
• Table 45 Latin America Tendonitis Treatment market, by country, 2016 - 2030 (USD Million)
• Table 46 Latin America Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
• Table 47 Latin America Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million
• Table 48 Brazil Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
• Table 49 Brazil Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)
• Table 50 Mexico Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
• Table 51 Mexico Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)
• Table 52 Argentina Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
• Table53 Argentina Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)
• Table 54 MEA Tendonitis Treatment market, by country, 2016 - 2030 (USD Million)
• Table 55 MEA Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
• Table 56 MEA Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)
• Table 57 South Africa Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
• Table 58 South Africa Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)
• Table 59 Saudi Arabia Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
• Table 60 Saudi Arabia Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)
• Table 61 UAE Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
• Table 62 UAE Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)

List of Figures

• Figure 1. Market segmentation
• Figure 2. Estimates and Forecast Timeline
• Figure 3. market research process
• Figure 4. Data triangulation techniques
• Figure 5. PriFigure ary research pattern
• Figure 6. Market research approaches
• Figure 7. Value-chain-based sizing & forecasting
• Figure 8. QFD Figure odeling for Market share assessFigure ent
• Figure 9. Market for Figure ulation & validation
• Figure 10. Tendonitis Treatment Market estiFigure ates and forecasts, 2016 - 2030 (USD Million)
• Figure 11. SegFigure ent outlook, 2016 - 2030, USD Million
• Figure 12. Strategy fraFigure ework outlook
• Figure 13. Tendonitis Treatment Market snapshot, (2021, USD Million)
• Figure 14. Penetration & growth prospect Figure apping
• Figure 15. ConsuFigure er behavior analysis
• Figure 16. North AFigure erica factors influencing tendonitis Treatment Market (%)
• Figure 17. Europe factors influencing tendonitis Treatment Market (%)
• Figure 18. Asia Pacific: factors influencing tendonitis Treatment Market (%)
• Figure 19. Latin AFigure erica: factors influencing tendonitis Treatment Market (%)
• Figure 20. Figure EA: factors influencing tendonitis Treatment Market (%)
• Figure 21. Technology iFigure pact analysis
• Figure 22. Tendonitis Treatment Market dynaFigure ics
• Figure 23. Tendonitis Treatment Market driver iFigure pact
• Figure 24. Tendonitis Treatment Market restraint iFigure pact
• Figure 25. Market participant categorization
• Figure 26. Regional network map
• Figure 27. Tendonitis Treatment Market: Market leaders and innovators
• Figure 28. CoFigure pany Market share analysis, 2021
• Figure 29. CoFigure pany Market share by region, 2021
• Figure 30. CoFigure pany Market position analysis
• Figure 31. Tendonitis Treatment Market: Treatment movement analysis
• Figure 32. Tendonitis Treatment Market Treatment dashboard
• Figure 33. Tendonitis Treatment Market: Condition movement analysis
• Figure 34. Tendonitis Treatment Market Condition dashboard
• Figure 35. Regional dashboard
• Figure 36. Regional Marketplace: Key takeaways
• Figure 37. Regional outlook, 2021 & 2030
• Figure 38. North AFigure erica Tendonitis Treatment Market share by countries, 2021
• Figure 39. Europe Tendonitis Treatment Market share by countries, 2021
• Figure 40. Asia Pacific Tendonitis Treatment Market share by countries, 2021
• Figure 41. Latin AFigure erica Tendonitis Treatment Market share by countries, 2021
• Figure 42. MEA Tendonitis Treatment Market share by countries, 2021
• Figure 43. North AFigure erica Tendonitis Treatment Market, 2016 - 2030 (USD Million)
• Figure 44. U.S. Tendonitis Treatment Market, 2016 - 2030 (USD Million)
• Figure 45. Canada Tendonitis Treatment Market, 2016 - 2030 (USD Million)
• Figure 46. Europe Tendonitis Treatment Market, 2016 - 2030 (USD Million)
• Figure 47. U.K. Tendonitis Treatment Market, 2016 - 2030 (USD Million)
• Figure 48. Germany Tendonitis Treatment Market, 2016 - 2030 (USD Million)
• Figure 49. France Tendonitis Treatment Market, 2016 - 2030 (USD Million)
• Figure 50. Italy Tendonitis Treatment Market, 2016 - 2030 (USD Million)
• Figure 51. Spain Tendonitis Treatment Market, 2016 - 2030 (USD Million)
• Figure 52. Russia Tendonitis Treatment Market, 2016 - 2030 (USD Million)
• Figure 53. Asia Pacific Tendonitis Treatment Market, 2016 - 2030 (USD Million)
• Figure 54. Japan Tendonitis Treatment Market, 2016 - 2030 (USD Million)
• Figure 55. China Tendonitis Treatment Market, 2016 - 2030 (USD Million)
• Figure 56. India Tendonitis Treatment Market, 2016 - 2030 (USD Million)
• Figure 57. South Korea Tendonitis Treatment Market, 2016 - 2030 (USD Million)
• Figure 58. Singapore Tendonitis Treatment Market, 2016 - 2030 (USD Million)
• Figure 59. Australia Tendonitis Treatment Market, 2016 - 2030 (USD Million)
• Figure 60. Latin AFigure erica Tendonitis Treatment Market, 2016 - 2030 (USD Million)
• Figure 61. Mexico Tendonitis Treatment Market, 2016 - 2030 (USD Million)
• Figure 62. Brazil Tendonitis Treatment Market, 2016 - 2030 (USD Million)
• Figure 63. Argentina Tendonitis Treatment Market, 2016 - 2030 (USD Million)
• Figure 64. MEA Tendonitis Treatment Market, 2016 - 2030 (USD Million)
• Figure 65. South Africa Tendonitis Treatment Market , 2016 - 2030 (USD Million)
• Figure 66. Saudi Arabia Tendonitis Treatment Market, 2016 - 2030 (USD Million)
• Figure 67. UAE Tendonitis Treatment Market, 2016 - 2030 (USD Million)

Tendonitis Treatment Market Growth & Trends:

The global tendonitis treatment market size is expected to reach USD 281.8 billion by 2030, registering a CAGR of 3.7% over the forecast period, according to a new report by Grand View Research, Inc. Growing participation in physical and sporting activities, directly influences the rise in prevalence of sports-related injuries. In addition, the rising incidence of occupational injuries is anticipated to contribute to the development and growth of the industry over the forecast period. The growing global geriatric population is susceptible to bone disorders, diabetes, arthritis, osteoarthritis, osteoporosis, or tendonitis. Industry participants that are constantly innovating advanced therapies and technologies in managing tendonitis are also contributing to the market growth.

Growing investments, industry collaborations, and increasing favorable government support are other key factors accelerating market growth. Over the past years, there has been a transition from proactive to preventive therapies in managing the health of sportspersons in preventing injuries. According to Standard Children's Health, in 2018, approximately 3.5 million out of 30 million adolescents participating in sporting activities in the U.S. incur sports-related injuries. As per studies, annually, around 775,000 adolescents receive therapies and treatments for sports-related injuries in the U.S. Major players are expanding their business footprint in both developed and emerging economies through product innovation and strengthening their distribution cycles.

During the COVID-19 pandemic and enforced lockdowns and travel restrictions imposed across countries, the industry growth was negatively impacted owing to a decline in the number of tendonitis treatment procedures. Postponement and cancellation of sporting events led to a decline in the incidence of sports-related injuries, thereby, resulting in a decline in the business performance of the market. In 2021, the therapy segment accounted for the largest share and is anticipated to grow significantly over the forecast period. This is owing to the high preference for non-invasive treatment procedures. The first line of treatment management is physical therapy, which is expected to witness considerable growth.

The Achilles tendonitis segment dominated the industry in 2021. This growth can be attributed to the growing incidence of sports-related injuries in sports players. As per studies, the incidence rate of Achilles tendonitis ranges between 5 to 10 individuals per 100,000 people. North America accounted for the largest share in 2021 owing to the presence of renowned manufacturers and distributors, growing incidence of sports-related & trauma injuries, and rising awareness about the availability of various therapies & surgical procedures.

Tendonitis Treatment Market Report Highlights:

• The industry is expected to have significant growth over the forecast period owing to the increasing participation in physical & sporting events, leading to a growth in the number of injuries, thereby requiring therapies and surgeries

• The emergence of innovative and advanced solutions is responsible for industry growth over the forecast period

• In 2021, the therapy treatment segment accounted for the largest revenue share owing to the increased preference for non-invasive treatment over the surgical procedure for tendonitis

• Based on the condition type, Achilles tendonitis held the largest revenue share in 2021 owing to the increased incidence of sports injuries

• North America was the largest region in 2021 on account of the high number of surgeries performed in the region

Table of Contents

Chapter 1 Research Methodology & Scope

• 1.1 Market Segmentation & Scope
  • 1.1.1 Estimates and Forecast Timeline
• 1.2 Research Methodology
• 1.3 Information Procurement
  • 1.3.1 Purchased database:
  • 1.3.2 GVR's Internal Database
  • 1.3.3 Secondary sources
  • 1.3.4 Primary Research:
  • 1.3.5 Details of Primary Research
• 1.4 List of Secondary Sources
• 1.5 List of Primary Sources
• 1.6 Information or Data Analysis
  • 1.6.1 Data Analysis Models
• 1.7 Market Formulation & Validation
  • 1.7.1 Approach 1: Commodity Flow Approach
  • 1.7.2 Global Market: CAGR Calculation
• 1.8 Abbreviations
• 1.9 Report Objectives

Chapter 2 Executive Summary

• 2.1 Market Outlook
  • 2.1.1 Tendonitis Treatment Market Estimates and Forecasts, 2016 - 2030 (USD Million)
• 2.2 Segment Outlook
• 2.3 Competitive Outlook
• 2.4 Tendonitis Market Summary, 2021

Chapter 3 Tendonitis Treatment Market Variables, Trends & Scope

• 3.1 Market Lineage Outlook
  • 3.1.1 Parent market analysis
  • 3.1.2 Ancillary market Analysis
• 3.2 Penetration & Growth Prospect Mapping
• 3.3 Pricing Analysis
• 3.4 Product Pipeline Analysis
• 3.5 Industry Analysis
  • 3.5.1 Consumer behavior analysis
  • 3.5.2 Market influencer analysis
    • 3.5.2.1 North America
    • 3.5.2.2 Europe
    • 3.5.2.3 Asia Pacific
    • 3.5.2.4 Latin America
    • 3.5.2.5 MEA
  • 3.5.3 List of key end-users, by product
• 3.6 Regulatory Framework
  • 3.6.1 Reimbursement framework
  • 3.6.2 Standards & compliance
    • 3.6.2.1 CPT Coding implications
    • 3.6.2.2 HCPCS Coding implications
  • 3.6.3 Safety
• 3.7 Tendonitis Treatment Market Dynamics
  • 3.7.1 Market driver analysis
    • 3.7.1.1 Increasing prevalence of sports injuries
    • 3.7.1.2 Technological advancements pertaining to novel product development
    • 3.7.1.3 Growing awareness of tendonitis treatment options
  • 3.7.2 Market restraint analysis
    • 3.7.2.1 Insurance coverage is limited in emerging countries
• 3.8 Tendonitis Treatment Market Analysis Tools
  • 3.8.1 Industry Analysis - Porters
    • 3.8.1.1 Supplier Power- Moderately High
    • 3.8.1.2 Buyer Power- Moderate
    • 3.8.1.3 Threat Of Substitutes- Moderate
    • 3.8.1.4 Threat Of New Entrants- Low
    • 3.8.1.5 Competitive Rivalary- High
  • 3.9.2 PESTEL Analysis
    • 3.9.2.1 Political Landscape
    • 3.9.2.2 Economic Landscape
    • 3.9.2.3 Social Landscape
    • 3.9.2.4 Technology Landscape
    • 3.9.2.5 Environmental Landscape
    • 3.9.2.6 Legal landscape
• 3.10. Major Deals & Strategic Alliances Analysis

Chapter 4 Tendonitis Treatment Market: Competitive Analysis

• 4.1 Market Participation Categorization
  • 4.1.1 Regional network map
  • 4.1.2 Innovators
  • 4.1.3 Key company market share analysis, 2021
  • 4.1.4 Company market share by region, 2021
• 4.2 Public Companies
  • 4.2.1 Company market position analysis
  • 4.2.2 Heat Map Analysis
• 4.3 Private Companies
  • 4.3.1 List of emerging companies
  • 4.3.2 Heat Map analysis
• 4.4 Vendor Landscape
  • 4.4.1 List of key distributors and channel partners
  • 4.4.2 Key customers

Chapter 5 Tendonitis Treatment Market: Treatment Estimates & Trend Analysis

• 5.1 Treatment Market Share Analysis, 2021 & 2030
• 5.2 Treatment Dashboard
  • 5.2.1 Therapy
    • 5.2.1.1 Therapy Market Estimates And Forecasts, 2016 - 2030 (USD MILLION)
    • 5.2.1.1.1 Hot and Cold Therapy
    • 5.2.1.1.2 Physical Therapy
    • 5.2.1.1.3 Shockwave Therapy
  • 5.2.2 Surgery
    • 5.2.2.1 Surgery Market Estimates And Forecasts, 2016 - 2030 (USD MILLION)

Chapter 6 Tendonitis Treatment Market: Condition Estimates & Trend Analysis

• 6.1 Condition Market Share Analysis, 2021 & 2030
• 6.2 Condition Dashboard
  • 6.2.1 Tennis Elbow
    • 6.2.1.1 Tennis Elbow market estimates and forecasts, 2016 - 2030 (USD Million)
  • 6.2.2 Golfer's Elbow
    • 6.2.2.1 Golfer's Elbow market estimates and forecasts, 2016 - 2030 (USD Million)
  • 6.2.3 Pitcher's Elbow
    • 6.2.3.1 Pitcher's Elbow market estimates and forecasts, 2016 - 2030 (USD Million)
  • 6.2.4 Jumper's Knee
    • 6.2.4.1 Jumper's Knee market estimates and forecasts, 2016 - 2030 (USD Million)
  • 6.2.5 Swimmer's Shoulder
    • 6.2.5.1 Swimmer's Shoulder market estimates and forecasts, 2016 - 2030 (USD Million)
  • 6.2.6 Achilles Tendonitis
    • 6.2.6.1 Achilles Tendonitis market estimates and forecasts, 2016 - 2030 (USD Million)

Chapter 9 Tendonitis Treatment Market: Regional Estimates & Trend Analysis, By Treatment, By Condition

• 9.1 Regional Dashboard
• 9.2 Regional Market Snapshot
• 9.3 Global tendonitis treatment market: Regional Movement Analysis
• 9.4 Market Share Analysis by Country, 2021
  • 9.4.1 North America
  • 9.4.2 Europe
  • 9.4.3 Asia Pacific
  • 9.4.4 Latin America
  • 9.4.5 MEA
• 9.5 North America
  • 9.5.1 North America Tendonitis Treatment Market estimates and forecasts, 2016 - 2030 (USD Million)
  • 9.5.2 U.S.
    • 9.5.2.1 U.S. Tendonitis Treatment Market estimates and forecasts, 2016 - 2030 (USD Million)
  • 9.5.3 Canada
    • 9.5.3.1 Canada Tendonitis Treatment Market estimates and forecasts, 2016 - 2030 (USD Million)
• 9.6 Europe
  • 9.6.1 Europe Tendonitis Treatment Market estimates and forecasts, 2016 - 2030 (USD Million)
  • 9.6.2 U.K.
    • 9.6.2.1 U.K. Tendonitis Treatment market estimates and forecasts, 2016 - 2030 (USD Million)
  • 9.6.3 Germany
    • 9.6.3.1 Germany Tendonitis Treatment market estimates and forecasts, 2016 - 2030 (USD Million)
  • 9.6.4 France
    • 9.6.4.1 France Tendonitis Treatment market estimates and forecasts, 2016 - 2030 (USD Million)
  • 9.6.5 Italy
    • 9.6.5.1 Italy Tendonitis Treatment market estimates and forecasts, 2016 - 2030 (USD Million)
  • 9.6.6 Spain
    • 9.6.6.1 Spain Tendonitis Treatment market estimates and forecasts, 2016 - 2030 (USD Million)
  • 9.6.7 Russia
    • 9.6.7.1 Russia Tendonitis Treatment market estimates and forecasts, 2016 - 2030 (USD Million)
• 9.7 Asia Pacific
  • 9.7.1 Asia Pacific Tendonitis Treatment market estimates and forecasts, 2016 - 2030 (USD Million)
  • 9.7.2 Japan
    • 9.7.2.1 Japan Tendonitis Treatment market estimates and forecasts, 2016 - 2030 (USD Million)
  • 9.7.3 China
    • 9.7.3.1 China Tendonitis Treatment market estimates and forecasts, 2016 - 2030 (USD Million)
  • 9.7.4 India
    • 9.7.4.1 India Tendonitis Treatment market estimates and forecasts, 2016 - 2030 (USD Million)
  • 9.7.5 South Korea
    • 9.7.5.1 South Korea Tendonitis Treatment market estimates and forecasts, 2016 - 2030 (USD Million)
  • 9.7.6 Singapore
    • 9.7.6.1 Singapore Tendonitis Treatment market estimates and forecasts, 2016 - 2030 (USD Million)
  • 9.7.7 Australia
    • 9.7.7.1 Australia Tendonitis Treatment market estimates and forecasts, 2016 - 2030 (USD Million)
• 9.8 Latin America
  • 9.8.1 Latin America Tendonitis Treatment market estimates and forecasts, 2016 - 2030 (USD Million)
  • 9.8.2 Mexico
    • 9.8.2.1 Mexico Tendonitis Treatment market estimates and forecasts, 2016 - 2030 (USD Million)
  • 9.8.3 Brazil
    • 9.8.3.1 Brazil Tendonitis Treatment market estimates and forecasts, 2016 - 2030 (USD Million)
  • 9.8.4 Argentina
    • 9.8.4.1 Argentina Tendonitis Treatment market estimates and forecasts, 2016 - 2030 (USD Million)
• 9.9 MEA
  • 9.9.1 MEA Tendonitis Treatment market estimates and forecasts, 2016 - 2030 (USD Million)
  • 9.9.2 South Africa
    • 9.9.2.1 South Africa Tendonitis Treatment market estimates and forecasts, 2016 - 2030 (USD Million)
  • 9.9.3 Saudi Arabia
    • 9.9.3.1 Saudi Arabia Tendonitis Treatment market estimates and forecasts, 2016 - 2030 (USD Million)
  • 9.9.4 UAE
    • 9.9.4.1 UAE Tendonitis Treatment market estimates and forecasts, 2016 - 2030 (USD Million)

Chapter 10 Company Profiles

• 10.1 Merck & Co. Inc
  • 10.1.1 Company overview
  • 10.1.2 Financial performance
  • 10.1.3 Product benchmarking
  • 10.1.4 Strategic initiatives
• 10.2 AstraZeneca
  • 10.2.1 Company overview
  • 10.2.2 Financial performance
  • 10.2.3 Product benchmarking
  • 10.2.4 Strategic initiatives
• 10.3 Boehringer Ingelheim Pharmaceuticals, Inc
  • 10.3.1 Company overview
  • 10.3.2 Financial performance
  • 10.3.3 Product benchmarking
  • 10.3.4 Strategic initiatives
• 10.4 Abbott
  • 10.4.1 Company overview
  • 10.4.2 Financial performance
  • 10.4.3 Product benchmarking
  • 10.4.4 Strategic initiatives
• 10.5 Pfizer
  • 10.5.1 Company overview
  • 10.5.2 Financial performance
  • 10.5.3 Product benchmarking
  • 10.5.4 Strategic initiatives
• 10.6 Bayer AG
  • 10.6.1 Company overview
  • 10.6.2 Financial performance
  • 10.6.3 Product benchmarking
  • 10.6.4 Strategic initiatives
• 10.7 GlaxoSmithKline, PLC
  • 10.7.1 Company overview
  • 10.7.2 Financial performance
  • 10.7.3 Product benchmarking
  • 10.7.4 Strategic initiatives
• 10.8 Almatica Pharma, Inc
  • 10.8.1 Company overview
  • 10.8.2 Financial performance
  • 10.8.3 Product benchmarking
  • 10.8.4 Strategic initiatives
• 10.9 Teva Pharmaceuticals Industries
  • 10.9.1 Company overview
  • 10.9.2 Financial performance
  • 10.9.3 Product benchmarking
  • 10.9.4 Strategic initiatives